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Abstract
Objectives—This study sought to find out more about the relationship between sympathetic and
vagal nerve activity and the cardiac repolarization in a canine model of pacing-induced tachycardia
congestive heart failure (CHF).
Background—The QT variability index (QTVI), a noninvasive marker of temporal cardiac
repolarization dispersion, is among the risk factors for sudden death during CHF. Among factors
influencing this variable are the myocardial damage and the autonomic nervous system activity
typical of dilated cardiomyopathy.
Methods—We assessed autonomic nervous system activity recorded from an implanted data
transmitter that monitored integrated left stellate-ganglion nervous activity, integrated vagus nerve
activity, and electrocardiogram. We collected 36 segments recorded at baseline and 36 after induced
CHF. We then arbitrarily identified recording segments as containing low or high sympathetic
activity values, and we compared corrected QT intervals and the QTVI under a given sympathetic
activity condition at baseline and after inducing CHF.
Results—In the high sympathetic activity subgroup, both QT variables increased from baseline to
CHF (corrected QT intervals, p < 0.01; QTVI, p < 0.05) whereas in the low sympathetic activity
subgroup they remained unchanged. The baseline QTVI correlated inversely with integrated vagus
nerve activity (r2 = 0.16; β = −0.47; p < 0.05) whereas, during CHF, the QTVI correlated directly
with integrated left stellate-ganglion nervous activity (r2 = 0.32; β = 0.27, p < 0.01).
Conclusions—During CHF, sympathetic activation is associated with an increase in the QT
interval and QTVI. Because these changes vary over time, they could result from myocardial
structural damage and sympathetic activation combined. Conversely, under normal conditions, no
relationship exists between sympathetic activation and the QT variables.
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Congestive heart failure (CHF) due to post-ischemic dilated cardiomyopathy is now among
the major known risk factors for sudden cardiac death (SCD). Though the complex mechanisms
underlying this phenomenon remain partly unclear, accumulating evidence suggests a major
role of the autonomic nervous system (ANS). According to the multifactorial mechanism
proposed by Zipes and Wellens (1), a sudden increase in sympathetic activity along with
diminished vagal nerve activity could act singly or in concert as transient events triggering
malignant ventricular arrhythmias culminating in SCD (1). Chronic neurohumoral activation
probably prepares the anatomic-functional CHF substrate (1) by inducing myocardial ion
channel dysfunction (2,3) thereby prolonging myocardial repolarization and increasing its
temporal dispersion. These electrophysiological changes are indirectly assessed with the QT
variability index (QTVI), a noninvasive measure of myocardial repolarization lability that is
typically increased in CHF (4–6) and correlates closely with an increased risk of SCD (7–9).
Notwithstanding the recent reports questioning the QTVI-ANS relationship (10) and criticizing
automated template methods for calculating the QT (11), given that the ANS can alter RR
interval variability then it could logically also alter QTVI (see formula in Methods section).
Previous studies have investigated these relationships with beta-blockers and maneuvers for
stimulating sympathetic nerve activity in healthy subjects and patients with CHF (5,6). Our
group recently introduced an invasive technique for directly measuring left stellate ganglion
nerve activity (SGNA), vagal nerve activity (VNA), and electrocardiogram (ECG) in
ambulatory dogs (12,13). Using this technique, in a previous study others in our research group
have already provided evidence that in dogs with CHF experimentally induced with an
elaborate protocol (including atrioventricular block, myocardial infarction, and infusion of
nerve growth factor), stimulation delivered to the left SGN prolongs the QT, the T-peak to T-
end interval, and induces tachycardia or ventricular fibrillation (14). What is now lacking is
direct evidence documenting the relationship between the ANS and temporal myocardial
repolarization dispersion during nonpharmacologically induced CHF.
To find out more about the relationships between the ANS and temporal myocardial
repolarization dispersion during CHF, we designed this experimental study using the canine
model of tachycardia pacing-induced CHF to investigate how the ANS influences the QTVI
(12). To clarify the influence of RR intervals on cardiac repolarization, we analyzed QT-RR
interval cross-spectral coherence.
Methods
Surgical preparation and electrical recording
The data analyzed came from a previous study conducted in 6 female dogs (12). The surgical
procedures and the temporal relationship between cardiac arrhythmia and ANS activity are
reported in detail elsewhere (12,15). In brief, a high-frequency pacing lead was implanted in
the right ventricular apex and connected to an Itrel neurostimulator (Medtronic, Minneapolis,
Minnesota) in a subcutaneous pocket. We then implanted a Data Sciences International (DSI)
D70-EEE transmitter (St. Paul, Minnesota) with 3 bipolar recording channels for simultaneous
recording of SGNA, VNA from the left thoracic vagal nerve located above the aortic arch, and
subcutaneous ECG. After implantation, the Itrel stimulator was initially turned off for 2 weeks
to allow the dogs to recover from surgery and to allow us obtain baseline recordings. The
stimulator was then programmed to pace at 150 beats/min for 3 days, at 200 beats/min for 3
days, and then at 250 beats/min for 3 weeks to induce CHF. The pacemaker was then turned
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off to allow an additional 2 weeks of ambulatory monitoring and recording during CHF. All
CHF data were recorded within the first week. All dogs underwent echocardiography and
venous blood sampling to determine serum N-terminal brain natriuretic peptide concentrations
at baseline and after rapid pacing. The animal experiments were approved by the Institutional
Animal Care and Use Committee.
Direct measurement of autonomic nervous activity
Data were recorded real time at a sampling rate of 1,000 samples per second per channel, then
analyzed offline. The custom-designed software used has been described elsewhere (12,15).
In brief, to analyze long-term trends in the large segmented data files effectively, a custom-
designed program was developed using Labview software to automatically import, filter, and
analyze the DSI transmitter data for ANS activities and heart rates. The software determined
the activation cycle lengths (RR intervals) automatically derived from ECG, based on a Hilbert
transform algorithm (16). Integrated data from the stellate ganglion (iSGNA) and vagal nerve
(iVNA) were high-pass (200 Hz) filtered and rectified over a fixed time segment (Figs. 1 and
2). Because RR intervals shorter than 200 ms were usually due either to ectopic beats, artifacts,
or rhythm disturbances, they were removed and excluded from analysis.
To assess ANS activity in greater detail, we selected ECG recording epochs lasting 300 s and
containing known iSGNA values (300 s iSGNA) and classified them into 2 subgroups, 1
containing low and the other high sympathetic activity levels, defined according to whether
the mean iSGNA value for the segment was over or below an arbitrary value of 80 mV (50th
percentile). A further 2 measures were calculated for integrated nerve activities: iSGNA and
iVNA over 24 h (24 h iSGNA and 24 h iVNA).
QT variability and QT-RR coherence
To calculate the QT interval and make the end of the T-wave easier to identify, we used a
software program based upon the algorithm for quantifying beat-to-beat fluctuations in QT
interval variability proposed by Berger et al. (4) and previously validated.
To obtain the QTVI from the 256-beat segments recorded, we calculated QT and RR mean
(QTm and RRm) and variances (QTv and RRv) (Figs. 3 and 4). The QTVI was then determined
with the following formula: QTVI = log10{[(QTv)/(QTm)2]/[(RRv)/(RRm)2]}. The digitalized
ECG recordings were analyzed by a single physician (G.P.).
The same 256-beat segments of ECG were analyzed with autoregressive power spectral (17)
and cross-spectral analysis (Fig. 3) (4,5). The next variable estimated was the coherence
function for the RR and QT intervals. Coherence expresses the fraction of power at a given
frequency in either time series and is explained as a linear transformation of the other, thus
providing an index of a linear association between the 2 signals (4,5). The coherence function
γ(f) was then computed according to the formula:
where f is frequency, Pxx (f) is the spectrum of an RR interval, Pyy (f) is the QT interval
spectrum, and Pxy (f) is the cross spectrum. The coherence function provides a measure between
zero and unity of the degree of linear interaction between RR and QT interval oscillations as
a function of their frequency. Mean coherences were measured by averaging γ(f) over the
frequency bands: from 0 to 0.50 Hz (Fig. 4).
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The QT interval was measured over 256 consecutive beats and corrected for heart rate. The
following QT interval corrections (QTc) were applied: (QTcBazett: QT/RR0.5), Fridericia
(QTcFridericia: QT/RR0.33), Tabo (QTcTabo: QT/RR0.3879), Van de Water (QTcVan de Water: QT
−0.087 [RR −1]) (18), and Framingham (QTcFramingham: QT +0.154 [1 − RR]).
Data and statistical analysis
For each dog, 6 recordings were obtained at baseline and 6 after pacing-induced CHF, 3
recordings at low sympathetic activity and 3 at high sympathetic activity values according to
iSGNA values. A total of 72 recordings were therefore analyzed, 36 obtained at baseline and
36 during CHF. A single rater (J.S.) randomly identified for each dog 6 recordings during CHF,
each lasting 5 min, having a good quality ECG trace, and then analyzed the corresponding
sympathetic activity recordings. The rater then identified for each dog 6 baseline recordings
having similar sympathetic activity and the corresponding 5-min ECG recordings. At baseline
and during CHF, the total number of ECG recordings was divided into 2 groups using iSGNA
values of 80 mV (50th percentile) as a cutoff. This procedure yielded 4 groups: baseline low
sympathetic activity (<50th percentile of iSGNA); baseline high sympathetic activity (<50th
percentile of iSGNA); CHF low sympathetic activity (<50th percentile of iSGNA); and CHF
high sympathetic activity (<50th percentile of iSGNA). For the statistical comparison between
the various groups, the variables obtained from the 5-min ECG recordings from the same dog
were randomly paired.
Unless otherwise indicated, all data are expressed as mean ± SD. Data with skewed distribution
are given as median and interquartile range (75th to 25th percentile). Paired t test was used to
compare data for the normally distributed variables (including RRm, QTm, QTc, QTVI, QT-
RRcoherence, 300 s iSGNA, and iVNA). Wilcoxon signed rank test was used to compare non-
normally distributed variables (including QTv and RRv) measured before and after pacing-
induced CHF and in the same dog subgroups (low or high sympathetic activity). Corrections
were not made for the use of multiple correlated observations within each animal in each
condition.
Because an increase in the variables evaluating cardiac repolarization (QTm, QTv, QTcBazett,
QTcFridericia, QTcTabo, QTcVan de Water, QTcFramingham, QTVI) indicates an unfavorable event,
we assessed for each variable during cardiac repolarization differences between low and high
sympathetic activity recordings during CHF, and differences in high sympathetic activity
between baseline and CHF recordings. Increased QTVI values were considered a “positive”
response and decreased QTVI a “negative” response. A McNemar test was therefore used to
substantiate that baseline data and pacing-induced changes in low sympathetic activity and
high sympathetic activity recordings differed statistically.
To assess the influence of the ANS on the studied variables at baseline and during pacing-
induced CHF, we used stepwise multiple regression analysis, again using as independent
variables natural logarithm (ln) iSGNA and ln iVNA, and as single dependent variables the
others (RRm, RRv, QTm, QTv, QTcBazett, QTcFridericia, QTcTabo, QTcVan de Water,
QTcFramingham, and QTVI). All data were evaluated with the database SPSS-PC+ (SPSS-PC+
Inc., Chicago, Illinois). A p value of ≤0.05 was considered statistically significant.
Results
After pacing-induced CHF, in all 6 ambulatory dogs studied the left ventricular ejection fraction
decreased significantly from baseline (from 56 ± 4% to 27 ± 7%, p < 0.0001). N-terminal brain
natriuretic peptide baseline levels increased (from <180 to 273 pmol/l at baseline, 558 to more
than 3,000 pmol/l on CHF day 1, and 405.7 ± 167 pmol/l [273 to 687 pmol/l] on CHF day 14
[p < 0.05]).
Piccirillo et al. Page 4
J Am Coll Cardiol. Author manuscript; available in PMC 2010 August 25.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
As expected, at baseline and after pacing-induced CHF, iSGNA values were significantly
higher in high sympathetic activity than in low sympathetic activity recordings (Table 1),
whereas no difference was found between iVNA values in the 2 subgroups. In all dogs, 24-h
iSGNA and 24-h iVNA values increased during the course of CHF (24-h iSGNA at baseline
143 ± 28 vs. during CHF 186 ± 95, p < 0.001; 24-h iVNA at baseline 3 ± 1 vs. 24-h during
CHF 8 ± 5, p < 0.001).
At baseline, RRm was significantly longer in low sympathetic activity than in high sympathetic
activity recordings (p < 0.05) (Table 1), whereas during pacing-induced CHF no difference
was found between the subgroups. Last, during CHF, RRv was significantly lower than at
baseline regardless of sympathetic activity levels (p < 0.05) (Table 1).
At baseline, QTm was significantly longer in the low sympathetic activity than in high
sympathetic activity recordings (p < 0.001) (Table 1). Conversely, during pacing-induced CHF,
QTm was significantly longer in the sub-group recorded at high than at low sympathetic activity
levels (Table 1). QTm in segments recorded at high sympathetic activity levels was significantly
shorter at baseline than during pacing-induced CHF (p < 0.001) (Table 1). At baseline, QTv
overlapped in the 2 subgroups. Conversely, after pacing-induced CHF, QTv was significantly
lower in low sympathetic activity than in high sympathetic activity recordings (p < 0.001)
(Table 1).
All of the corrected QT interval values (QTcBazett, QTcFridericia, QTcTabo, QTcVan de Water, and
QTcFramingham) measured in the subgroup with high sympathetic activity levels were
significantly higher during pacing-induced CHF than at baseline (p < 0.01) (Table 1). During
CHF, all these corrected QT values were higher in low sympathetic activity than in high
sympathetic activity recordings (p < 0.01).
During pacing-induced CHF, QTVI values were significantly higher in segments recorded at
high sympathetic activity levels than in those at low levels (−2.63 ± 0.50 vs. −2.20 ± 0.26, p
< 0.01), and at high sympathetic levels were also significantly higher during CHF than at
baseline (p < 0.05) (Fig. 5). At baseline, no difference was found between QTVI values in
segments recorded at low and high sympathetic activity levels (−2.51 ± 0.38 vs. −2.57 ± 0.66,
p = 0.796) (Fig. 5).
At baseline, mean coherence was significantly greater in segments recorded at high than at low
sympathetic activity levels (0.661 ± −0.1330 vs. 0.550 ± −0.139, p < 0.05) (Fig. 6) whereas no
significant difference was found in this variable between the 2 sympathetic activity subgroups
during CHF (low sympathetic activity 0.575 ± 0.153 vs. high sympathetic activity 0.589 ±
0.187, p = 0.814) (Fig. 6). Of the 18 comparisons between QTVI values recorded at low and
high sympathetic activity levels during CHF, in 15 comparisons QTVI values increased (chi-
square 6.7, p = 0.008). In the 3 comparisons in which QTVI decreased, the recordings came
from 3 different dogs. The other QT-related variables showed a similar pattern of changes: in
17 of the 18 comparisons QTv increased (chi-square 12.5, p < 0.0001), and in all 18
comparisons corrected QT values were higher in high sympathetic activity than in low
sympathetic activity recordings (chi-square 16.0, p < 0.0001). In the comparison between the
2 conditions baseline versus CHF, both recorded at high sympathetic levels, in all 18
comparisons QTVI and all the other QT variables studied increased (chi-square 16.0, p <
0.0001).
The stepwise multiple regression analysis testing data recorded at baseline detected a
significant positive relation between iVNA and RR interval duration, RRv and all QTcs (Table
2). Under the same condition, the QTVI also correlated negatively with iVNA (Table 2).
Conversely, the regression analysis testing data recorded after pacing-induced CHF detected
a significant positive relationship between iSGNA and QTv, all QTcs, and QTVI (Table 3).
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Discussion
In this study using pacing-induced CHF in ambulatory dogs, as well as confirming the
relationship between the ANS and temporal myocardial repolarization dispersion as assessed
by the QTVI, we provide new, direct evidence showing an association between sympathetic
activity and the QTVI, at least during CHF. The clinical importance of this research finding
resides in the knowledge that an increased QTVI is related to an increased risk of sudden death
(7–9). We achieved these results thanks mainly to the novel experimental approach that enabled
us to assess ANS activity and myocardial repolarization in ambulatory dogs uninfluenced by
pharmacological treatment or other confounding factors.
QT, QTVI, ANS, and pathophysiological implications
Our findings show that even though vagal modulation in normal conditions lengthens the RR
interval and QT interval this change is balanced by the increased RRv and by the constant
QTv, thus reducing the QTVI (Table 2). Conversely, during CHF, the subgroup with high
sympathetic activity had a high QTVI due primarily to increased QTv. This increased QTVI
probably reflects the structural myocardial damage and chronic neurohumoral activation that
characterizes CHF. Our findings in this experimental study provide direct evidence that neural
activity and QTVI are correlated (at least during CHF) albeit possibly not causally related thus
strengthening our previous observations in patients with CHF receiving sympathetic
stimulation (5). The ANS, and especially sympathetic nerve modulation, therefore seem able
to cause chronic myocardial repolarization lability ultimately leading to malignant ventricular
arrhythmias through a mechanism involving trigger activity, or reentry, or both (20,21). The
myocardial tendency to undergo similar mechanisms can be indirectly measured in vitro as an
increase in transmural dispersion of repolarization (TDR), namely the maximum difference in
the duration of the cardiac action potential between the various myocardial layers (20,21). An
increased TDR induces the so-called discordant and concordant repolarization alternans (22–
25), and this repolarization phenomenon depends on the prolonged M cell action potential
(22). A marked action potential prolongation in M cells causing augmented TDR nevertheless
becomes evident in abnormal conditions associated with increased arrhythmia susceptibility,
such as congenital long QT syndrome but also CHF. Reduced IKs, however, amplifies TDR
only in the presence of beta-adrenergic influence, due to a larger augmentation of residual
IKs in epicardial and endocardial cells than in M cells. Indeed, sympathetic activity could be
responsible for both the increased TDR and augmented QTVI, thus explaining why these 2
variables both correlate strictly with SCD (7–9,25–27).
In a recent study in healthy subjects, we observed that during sympathetic stimulation the
duration of myocardial repolarization diminishes whereas the QTVI remains almost
unchanged. Conversely, during CHF the QT interval lengthened, and the variables QTv and
QTVI increased (5). The mechanisms underlying the prolonged QT interval and QTv during
sympathetic activation in CHF remain unclear. Whereas some investigators attribute the CHF-
induced QT changes to faulty regulation of Ca2+ cytosol channels (26), others invoke down-
regulation of potassium channels (Ito, IKr, IKs, and IK1) (27). During CHF, the mechanisms
involving altered control of Ca2+ or K+ channels might, however, operate together their
contribution varying from individual to individual thus explaining prolonged myocardial
repolarization.
Repolarization reserve and the ANS
The concept of repolarization reserve denotes functioning ion channel redundancy that can
compensate for damaged channels if necessary (28). For example, a genetically weak IKs does
not necessarily lead to overt long QT syndrome type 1 because a robust compensatory function
of IKr maintains normal cardiac repolarization. Nevertheless in individuals with weak IKs,
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torsade de pointes can more easily be triggered during certain morbid conditions (including
hypopotassemia, fever, myocardial ischemia, and CHF) or also after administration of IKr
inhibitors (including d-sotalol, dofetilide, amiodarone, and macrolides) (28). Similarly, we
conjecture that the prolonged QT interval we observed during sympathetic activation after
pacing-induced CHF in the canine model used in this study arises through a mechanism that
modulates Ca2+ and K+ channel function, ultimately reducing repolarization reserve. A minor
point to consider in interpreting our results is that rather than merely increasing sympathetic
and reducing vagal activity, CHF induces wide fluctuations in QT duration (12). Hence, CHF
might also lead to wide temporal fluctuations in repolarization reserve including times when
sympathetic activity predominates characterized by a larger reduction in repolarization reserve
and a greater predisposition to arrhythmic events (12) and safer times of vagal predominance.
Although others have already reported a prolonged QT during sympathetic activation in
experimental models in vitro and during electrical stellate ganglion stimulation in vivo (14),
to our knowledge our study is the first to provide direct evidence confirming this finding in an
experimental model using live animals free to move, and most important, without
pharmacological interference.
Cross-spectral analysis of RR and QT intervals
Cross-spectral analysis was introduced by Berger et al. (4) in the first study on QTVI designed
to show that RR interval and QT variables agreed. Coherence is measured as the R correlation
factor: a high spectral coherence value is near 1, a low spectral coherence value is close to 0.
Albeit controversial (29), a coherence value of less than 0.500 is arbitrarily considered to reflect
low coupling, especially for certain cardiovascular signals (i.e., between heart rate and blood
pressure) (30–32). In their original study, Berger et al. (4) reported relatively low spectral
coherence between RR and QT (<0.500) and later studies confirmed this low value also in
healthy subjects (6,33,34) and in patients with CHF (6,33,34). In our study, conducted in a
canine model of CHF, we achieved extraordinarily high spectral coherence values, almost twice
as high as those reported in studies in humans.
This elevated QT-RR coherence suggests that the 2 signals vary in parallel and that our
recording technique yields a qualitatively excellent, noise-free QT signal (noise having a
stochastic distribution). Some investigators question the template method of studying the QT
(11), underlining that this technique yields recordings with high noise levels. Hence, under our
experimental conditions, the QT template method seems an excellent technique. Although we
cannot explain why the canine model yields such high spectral coherence, a possible reason is
that ECG signals recorded from dogs remain uninfluenced by skin impedance because the
recording electrodes are implanted subcutaneously. An alternative explanation is that recording
electrode montages differ in humans and dogs. Whereas in humans recording electrodes are
placed according to a standard montage (leads II or III), in dogs they are placed in the best site
for exploring the electrical field crossed by the major depolarization vector in the left ventricle
(1 electrode is positioned proximally and anteriorly to the left hemithorax and the other
posteriorly and distally in a lower position). Last, we cannot exclude the possibility that canine
Ca2+ and K+ channels might be more sensitive to ANS activity than the corresponding channels
in human myocardium.
Further support for the close relationships between the ANS and temporal myocardial
repolarization dispersion came from our finding that at baseline QT-RR coherence values were
higher in the subgroup with high sympathetic activity values than in those recorded at low
values, whereas during CHF we found no difference between the 2 subgroups (Fig. 6), but
QTv and the QTVI (indexes of temporal myocardial repolarization dispersion) increased. The
increased QTv during CHF during high sympathetic activity leads to temporal QT-RR interval
coherence (4). The increased coherence at baseline in segments recorded at high sympathetic
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activity values was a partially unexpected finding. One explanation for this phenomenon is
that in mammals IKs channels normally take no more than a minor part in cardiac repolarization
under conditions of normal heart rate (35–37), whereas IKr channels play a major role (37).
When adrenergic stimulation causes the heart rate to increase, then IKs channels act to adapt
repolarization: the shorter the cycle length the greater the need for rapid repolarization and
recruitment of all available potassium channels (36,37). From this viewpoint, the increased
QT-RR interval coherence we observed under healthy conditions could be interpreted as a
marker of adequate IKs channel recruitment, whereas during CHF IKs channels being down-
regulated, the foregoing mechanisms function inadequately, and QT-RR coherence remains
constant even though QTv and, hence, QTVI increase.
Study limitations
In this study we recorded ANS activity from the vagal nerve and left stellate ganglion because
these nerves exert the major direct influence on cardiac repolarization (14,38). Although RR
interval variability is influenced above all by right sympathovagal innervation to the sinus
node, unfortunately the DSI we used comprises only 3 recording channels and we especially
sought detailed information on cardiac repolarization. Nevertheless, we have already shown
in a previous study a good correlation between right and left sympathetic activity a single
recording channel probably suffices to guarantee the knowledge of global sympathetic
innervation (39) in dogs.
A second limitation of the study is that although all the segments analyzed were obtained within
the first week after inducing CHF, we discarded those obtained immediately after turning the
pacemaker off. We did so because they contain innumerable arrhythmias, whereas study
protocols designed to investigate heart rate or QT variability require at least 256 consecutive
beats in sinus rhythm. The chosen timing probably has the disadvantage of excluding epochs
recorded during maximal sympathetic activity and allowing dogs slight vagal recovery (40).
A third limitation is that rather than assessing eventual changes in myocardial repolarization
close to an acute event, our study assesses electrical remodeling during CHF. As did Berger et
al. (4) in their first report, we merely observed that CHF is associated with increased
sympathetic activity and increased temporal dispersion in myocardial repolarization,
conditions that favor the onset of malignant ventricular arrhythmias.
Another limitation is that we have no information on the type of activity or the dog’s position
when data were recorded. Yet, insofar as QT analysis requires noise-free recordings, our data
most probably refer to dogs at rest. From a point of view of ANS, what matters most is not
what the dog was doing when the data were recorded but the changes associated with the
activity. In other words, regardless of whether dogs were asleep or awake, the scope of our
study was not to assess which of the 2 conditions induces major sympathetic activation but to
find out whether major sympathetic activation is associated with altered myocardial
repolarization under normal conditions and during CHF.
Last, the heart rate we recorded in ambulatory dogs at given levels of sympathetic activity and
vagal control was lower before than during CHF (Table 1). This finding might easily be
explained by the fact that during CHF the larger amounts of surrenal circulating epinephrine
could stimulate cardiac beta-receptors and maintain a higher heart rate, but to prove this
mechanism we would need to study cardiac catecholamine spillover. Another more speculative
explanation is that if levels of 1 neurotransmitter decline then the other maintains heart rate
levels high although adrenaline alone is unable to shorten the duration of cardiac repolarization.
Finally, the increased heart rate we observed during CHF might depend on sinus dysfunction
and electrical remodeling (41).
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Conclusions
Whereas our study shows an association between augmented sympathetic activity and the
increased QTVI during CHF, it provides no evidence of a similar association under normal
conditions. The findings obtained in this CHF canine model suggest that the QTVI—an index
closely related to the risk of SCD (7–9)—could also be used as a reliable marker of
neurohumoral activation and, hence, of disease progression.
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Abbreviations and Acronyms
ANS  
autonomic nervous system
CHF  
congestive heart failure
DSI  
Data Sciences International
iSGNA  
integrated left stellate-ganglion nervous activity
iVNA  
integrate vagus nerve activity
QTc  
corrected QT interval
QTm  
QT mean
QTv  
QT variance
QTVI  
QT variability index
RRm  
RR mean
RRv  
RR variance
SCD  
sudden cardiac death
TDR  
transmural dispersion of repolarization
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Figure 1. Nerve and ECG Recordings
Example of simultaneous integrated stellate ganglion nerve activity (iSGNA) and integrated
vagal nerve activity (iVNA) at baseline (before pacing-induced congestive heart failure) in an
ambulatory dog. (Top) iSGNA; (middle) iVNA; (bottom) electrocardiographic (ECG) trace.
In the upper trace, A indicates between the 12th and 16th s, an epoch of high sympathetic
activity followed 3 s later by an epoch of fast heart rate (about 120 beats/min, between the 18th
and 24th s). This sympathetic activity is followed almost immediately, between the 24th and
30th s, by a vagal increase with lower heart rate (B) (from 120 to 90 beats/min, between the
30th and 36th s), and last (C), a new increase in sympathetic activity after the 48th s, and a
heart rate increase (from 90 to 130 beats/min, around the 54th s). LSG = left stellate ganglion
nerve; VN = vagal nerve.
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Figure 2. Integrate Nerve Recordings and QT Interval
Example of assessment of iSGNA, iVNA, and its influence on RR and QT intervals at baseline
and after pacing-induced congestive heart failure (CHF) in an ambulatory dog. QTc = corrected
QT interval; other abbreviations as in Figure 1.
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Figure 3. RR and QT Intervals in 256 Beats
RR and QT intervals recorded in the same dog at baseline (A and C) and during congestive
heart failure (CHF) (B and D) under the same sympathetic activity levels. A and C show the
RR recorded and QT intervals over 256 consecutive cycles at baseline, and B and D show the
same data during CHF.
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Figure 4. Power Spectral Analysis, Coherence, and QTVI
RR and QT spectra obtained from the recordings of Figure 3. As in Figure 3, we reported the
spectrum in the same dog at baseline (left panels) and during congestive heart failure (CHF)
(right panels) under the same sympathetic activity levels. Panel A shows the power spectra
for RR intervals at baseline, panel B during CHF. Note the dramatic reduction in RR-interval
variance (RRv), less than two-thirds the value during CHF, and the reduced RR interval
(RRm). Panels C and D show the spectra for QT intervals recorded at baseline and during
CHF. Note that QT variance (QTv) and the mean QT interval (QTm) both increase. Last, panels
E (baseline) and F (CHF) give coherence and corresponding QT variability index (QTVI)
values calculated from the respective RR (baseline: A; CHF: B) and QT intervals (baseline:
C; CHF: D) (QTVI = QTv/[QTm]2/RRv/[RRm]2). Note the increased QTVI during CHF. Note
also that maximum coherence at baseline peaks at around 0.1 Hz and during in CHF at around
0.35 Hz. The maximum peak differs because the 2 synchronous spectral components RR (A)
and QT (C) predominantly oscillate at a lower frequency at baseline than during CHF (0.1 and
0.35 Hz) (B and D). PSD = power spectral density in the area under the curve.
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Figure 5. QTVI Changes in Baseline and in CHF
In the subgroup recorded at high sympathetic activity values, the QTVI was significantly lower
at baseline than during CHF. In the box plots, the central line represents the median
distribution. Each box spans from 25th to 75th percentile points, and error bars extend from
10th to 90th percentile points. iSGNA = integrated stellate ganglion nerve activity; other
abbreviations as in Figure 4.
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Figure 6. QT-RR Coherence Changes Between Baseline and CHF
Graph showing cross-spectral analysis (coherence) in the 6 ambulatory dogs. Note that baseline
coherence increases as a function of the increase in spectral sympathetic nerve activity. In the
box plots, the central line represents the median distribution. Each box spans from 25th to
75th percentile points, and error bars extend from 10th to 90th percentile points. CHF =
congestive heart failure; iSGNA = integrated stellate ganglion nerve activity.
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